Milestone Pharmaceuticals Inc. (MIST)
USD 1.7
(-6.59%)
USD 1.7
(-6.59%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1 Million | 5 Million | 15 Million | - | - | - |
| Cost of Revenue | 598 Thousand | 480 Thousand | - | 376 Thousand | 236 Thousand | 10 Thousand |
| Gross Profit | 402 Thousand | 4.52 Million | 15 Million | -376 Thousand | -236 Thousand | -10 Thousand |
| Operating Expenses | 62.09 Million | 64.64 Million | 58.07 Million | 50.71 Million | 57.88 Million | 23.82 Million |
| Selling, General and Administrative Expenses | 31.04 Million | 24.81 Million | 19.4 Million | 16.22 Million | 15.89 Million | 6.97 Million |
| Research and Development Expenses | 31.05 Million | 39.82 Million | 38.67 Million | 34.48 Million | 41.98 Million | 16.84 Million |
| Other Expenses | - | - | 7 Million | - | - | - |
| Cost and Expenses | 62.09 Million | 64.64 Million | 58.07 Million | 50.71 Million | 57.88 Million | 23.82 Million |
| Operating Income | -61.09 Million | -59.64 Million | -43.07 Million | -50.71 Million | -57.88 Million | -23.82 Million |
| Interest Expense | 2.55 Million | - | - | 726 Thousand | 2.59 Million | - |
| Income Tax Expense | - | -1.25 Million | -220 Thousand | -17 Thousand | -56 Thousand | 74 Thousand |
| Earnings before Tax | -59.68 Million | -58.38 Million | -42.85 Million | -49.98 Million | -55.28 Million | -23.11 Million |
| Net Income | -59.68 Million | -57.13 Million | -42.63 Million | -49.96 Million | -55.22 Million | -23.18 Million |
| Earnings Per Share Basic | -1.39 | -1.35 | -1.02 | -1.70 | -3.50 | -0.98 |
| Earnings Per Share Diluted | -1.39 | -1.35 | -1.02 | -1.70 | -3.50 | -0.98 |
| Weighted Average Shares Outstanding | 42.95 Million | 42.45 Million | 41.83 Million | 29.34 Million | 15.78 Million | 23.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 42.95 Million | 42.45 Million | 41.83 Million | 29.34 Million | 15.78 Million | 23.64 Million |
| Gross Margin | 0.40 | 0.90 | 1.00 | - | - | - |
| EBIT Margin | -56.84 | -11.93 | -2.87 | - | - | - |
| Profit Margin | -59.68 | -11.43 | -2.84 | - | - | - |
| EBITDA | -56.84 Million | -58.36 Million | -42.98 Million | -50.71 Million | -57.88 Million | -23.35 Million |
| Earnings Before Tax Margin | -61.10 | -11.93 | -2.87 | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 1 Million | -868 Thousand | - | - |
| Cost of Revenue | 26 Thousand | 28 Thousand | 598 Thousand | 532 Thousand | 23.99 Thousand | 24 Thousand |
| Gross Profit | -26 Thousand | -28 Thousand | 402 Thousand | -1.4 Million | -23.99 Thousand | -24 Thousand |
| Operating Expenses | 9.7 Million | 10.51 Million | 61.81 Million | 13.34 Million | 15.36 Million | 16.43 Million |
| Selling, General and Administrative Expenses | 6.82 Million | 6.8 Million | - | 7.9 Million | 8.63 Million | 7.81 Million |
| Research and Development Expenses | 2.88 Million | 3.7 Million | - | 5.43 Million | 6.72 Million | 8.62 Million |
| Other Expenses | -65 Thousand | - | - | - | - | - |
| Cost and Expenses | 9.72 Million | 10.54 Million | 62.41 Million | 13.87 Million | 15.36 Million | 16.43 Million |
| Operating Income | -9.72 Million | -10.54 Million | -61.41 Million | -13.87 Million | -15.36 Million | -16.43 Million |
| Interest Expense | 887 Thousand | 872 Thousand | 2.55 Million | 857 Thousand | 841 Thousand | 820 Thousand |
| Income Tax Expense | -65 Thousand | -68 Thousand | -312 Thousand | -74 Thousand | 1.12 Million | 1.21 Million |
| Earnings before Tax | -9.42 Million | -10.42 Million | -59.99 Million | -13.68 Million | -15.08 Million | -16.04 Million |
| Net Income | -9.36 Million | -10.35 Million | -59.68 Million | -13.61 Million | -15.08 Million | -16.04 Million |
| Earnings Per Share Basic | -0.14 | -0.21 | - | -0.41 | -0.35 | -0.37 |
| Earnings Per Share Diluted | -0.14 | -0.21 | - | -0.41 | -0.35 | -0.37 |
| Weighted Average Shares Outstanding | 66.16 Million | 50.15 Million | 42.95 Million | 33.48 Million | 42.97 Million | 42.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 66.16 Million | 50.15 Million | 42.95 Million | 33.48 Million | 42.97 Million | 42.93 Million |
| Gross Margin | - | - | 0.40 | 1.61 | - | - |
| EBIT Margin | - | - | - | 15.37 | - | - |
| Profit Margin | - | - | -59.68 | 15.68 | - | - |
| EBITDA | -9.7 Million | -10.51 Million | - | -13.34 Million | -14.21 Million | -15.19 Million |
| Earnings Before Tax Margin | - | - | -61.41 | 15.98 | - | - |
4772
CREVW
GEA
1026
6D81
S29